GenMark Diagnostics Profile

USD 0.08  1.47%

Sale by Michael Gleeson of 1933 shares of GenMark Diagnostics

GenMark Diagnostics Inc insider trading alert for sale of common stock by Michael Gleeson, SVP North American Com. Ops., on March 14, 2018. This event was filed by Genmark Diagnostics Inc with SEC on 2017-08-23. Statement of changes in beneficial ownership - SEC Form 4. Michael Gleeson is currently serves as sr. vp of north american commercial operations of GenMark Diagnostics Inc [view details]   

GenMark Diagnostics Summary

GenMark Diagnostics Inc (GNMK) is traded on NASDAQ General Markets in USA. It is located in CALIFORNIA, U.S.A and employs 517 people. GenMark Diagnostics is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 318.86 M. GenMark Diagnostics Inc conducts business under Healthcare sector and is part of Medical Equipment industry. This company has 55.17 M outstanding shares of which 7.78 M shares are currently shorted by private and institutional investors with about 7.09 trading days to cover. GenMark Diagnosti currently holds about 71.99 M in cash with (53.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.3.
Check GenMark Diagnostics Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Price T Rowe Associates IncCommon Shares8.8 M36.8 M
Fmr LlcCommon Shares8.2 M34.3 M
View GenMark Diagnostics Diagnostics

Selected GenMark Diagnostics Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

GenMark Diagnostics Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 39% 
Equity ratings for GenMark Diagnostics Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular tests based on its proprietary eSensor electrochemical detection technology. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California. GenMark Diagnostics operates under Medical Appliances Equipment classification in USA and traded on NASDAQ General Markets. It employs 517 people. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
NameGenMark Diagnostics Inc
CEO and President and DirectorHany MassaranyView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
RegionNorth America
Business Address5964 La Place Court
ExchangeNASDAQ General Markets
CIK Number01487371.0
IndustryMedical Equipment
Contact Number760 448 4300
CurrencyUSD - US Dollar


GenMark Diagnostics Analyst Recommendations
Target PriceAdvice# of Analysts
GenMark Diagnostics Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
GenMark Diagnostics Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


GenMark Diagnostics Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.3February 28, 2017
GenMark Diagnostics Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


GenMark Diagnostics Corporate Directors
Kevin OBoyle Independent Director
James Fox Independent Director
Michael Kagnoff Director